46 filings
Page 2 of 3
F-1/A
sr7iquo4 28rl
6 May 24
Registration statement (foreign) (amended)
8:27pm
F-1/A
35xu8j4 bzgv
18 Apr 24
Registration statement (foreign) (amended)
6:03am
6-K
eno4iqcol8kmt sit
15 Mar 24
Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares
5:10pm
6-K
5pqyqk
12 Mar 24
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
5:25pm
F-1
nw2f7je9k2vd9en
9 Feb 24
Registration statement (foreign)
4:09pm
20-F
exhei
31 Jan 24
Annual report (foreign)
5:05pm
CERT
oub71578j
26 Jan 24
Certification of approval for exchange listing
12:00am
8-A12B
1hnwbjot
25 Jan 24
Registration of securities on exchange
5:24pm
425
9tkgxiyu 8e
22 Jan 24
Business combination disclosure
9:53pm
425
fc94jkqym637xmp rv
17 Jan 24
Business combination disclosure
6:00am
425
bgla3pqp sp5kmxn6
15 Nov 23
Business combination disclosure
5:15pm
424B3
d7q yj9fwf
15 Nov 23
Prospectus supplement
4:28pm
SEC STAFF
je474emeq06r850
15 Nov 23
SEC staff action: Order
12:00am
F-4/A
g6uw tvc2elb
13 Nov 23
Registration of securities (foreign) (amended)
3:59pm
F-4/A
8pu2di8mh
13 Nov 23
Registration of securities (foreign) (amended)
9:27am
EFFECT
sn6cg 39uhye
13 Nov 23
Notice of effectiveness
12:00am
CORRESP
s8aheks1i7m3vayokk
13 Nov 23
Correspondence with SEC
12:00am
F-4/A
tuola4y1pwk
3 Nov 23
Registration of securities (foreign) (amended)
6:17pm
CORRESP
4uj8 pzw51f50yd5th
3 Nov 23
Correspondence with SEC
12:00am
UPLOAD
wgaaf444e07u3g5g515
25 Oct 23
Letter from SEC
12:00am